Options Brief: AMAG Pharmaceuticals (AMAG)

Shares of AMAG Pharmaceuticals AMAG are higher on the session by 13.59%, currently trading at $15.96. Put volume is now running at 5.94x the daily average, with 1% of all puts traded being purchases on the offer. 2,644 put contracts have traded so far during the session. AMAG Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic iron compounds to treat iron deficiency anemia in the United States, Europe, and Japan. It also provides novel imaging agents to aid in the diagnosis of cancer and cardiovascular diseases.